PMS2 and mismatch repair cancer syndrome 1: Hypermutation (TMB: 107.74 mut/Mb) driven by MMR deficiency mutational signatures (COSMIC)14,15 (Fig. 2c), loss of PMS2 protein expression, and high exomic MSI burden (1830) were detected.